Key result
Doubling D-dimer is linked to ~62% greater multi-territory infarction risk in stroke patients with active cancer.
Why the study?
The prevalence and clinical relevance of non-coagulopathy phenotypes in patients with active cancer experiencing ischemic stroke are not well defined.
Is elevated D-dimer associated with multi-territory infarction in patients with active cancer and ischemic stroke?
Cohort (n=182)
Blinded outcome assessment
No
Is elevated D-dimer associated with multi-territory infarction in patients with active cancer and ischemic stroke?
Effect estimate: adjusted OR 1.62 (95% CI 1.33-1.98)
p-value: p=<0.001
While multi-territory infarction with elevated D-dimer is a strong marker for cancer-associated coagulopathy, it represents a minority of strokes in active cancer patients, suggesting most require standard mechanism-oriented stroke work-up.
BackgroundCancer-related ischemic stroke is commonly suspected when diffusion-weighted imaging (DWI) shows multi-territory infarction with markedly elevated D-dimer. However, the prevalence and clinical relevance of non-coagulopathy phenotypes in patients with active cancer are not well defined.MethodsWe retrospectively studied consecutive ischemic stroke admissions undergoing MRI-DWI at a single center. Active cancer was defined as diagnosis or treatment within 6 months, or metastatic/recurrent disease. Infarct distribution (multi- vs. single-territory) was classified from official routine radiology reports by board-certified radiologists blinded to outcomes. We compared D-dimer across groups defined by cancer status and DWI distribution and examined predictors of multi-territory infarction within the active-cancer cohort using multivariable logistic regression.ResultsAmong patients with active cancer (n = 182), 25.3% (46/182) had multi-territory infarction and 74.7% (136/182) had single-territory infarction. D-dimer was higher in active-cancer patients with multi-territory infarction (median 6.8 μg/mL; IQR 1.3–14.2) than in active-cancer patients with single-territory infarction (median 1.2 μg/mL; IQR 0.5–3.3) and in non-cancer stroke groups (p < 0.001). Each doubling of D-dimer was independently associated with multi-territory infarction (adjusted OR 1.62; 95% CI 1.33–1.98).ConclusionsRoutine report-based phenotyping indicates that the classic coagulopathy phenotype is a strong marker but represents a minority of strokes with active cancer. When multi-territory infarction accompanies elevated D-dimer, evaluation should prioritize malignancy activity, systemic thrombosis/coagulopathy, and non-bacterial thrombotic endocarditis; otherwise, a mechanism-oriented stroke work-up should be maintained, with attention to cancer treatment– and radiation-related vascular injury.
No takes yet. Share an insight, caveat, or question.
Muraoka et al. (2026) conducted a cohort in Cancer-associated ischemic stroke (n=182). D-dimer level was evaluated on Multi-territory infarction (adjusted OR 1.62, 95% CI 1.33-1.98, p=<0.001). Each doubling of D-dimer was independently associated with multi-territory infarction in patients with active cancer and ischemic stroke (adjusted OR 1.62; 95% CI 1.33-1.98).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: